CBD Manufacturer Ispire Completes its Initial Public Offering, Raising $18.9 Million in Funding

Market by Globenewswire; Rui Tian
Apr.11.2023
CBD manufacturer Ispire announced the completion of its initial public offering, issuing 2.7 million common shares and raising $18.9 million in funding.

On April 6th, two breaking news stories about CBD manufacturer Ispire Technology Inc. (NASDAQ stock code: ISPR) were announced. The company completed its initial public offering, issuing 2.7 million common shares at $7.00 per share. The total amount raised was approximately $18.9 million (equivalent to RMB 130 million), excluding underwriting discounts and commissions as well as estimated offering expenses.

 

The common shares began trading on the NASDAQ Capital Market on April 4th. In addition, two selling shareholders can provide 1.75 million common shares based on the prospectus.

 

As previously reported, the funds raised from this offering will be used for:

  • About 35% for developing manufacturing business in Vietnam and the United States
  • Approximately 25% for research and development activities, including the development of new products and new e-cigarette technologies
  • About 20% for marketing and promotion of the company's branded products
  • The remaining approximately 20% for general administrative management and operating funds.

 

Also read:

【1】CBD制造商Ispire公布首次公开募股定价:每股7美元 发行270万股

 

Reference:

【1】Ispire Technology Inc. Announces Closing of Initial Public Offering

*The content of this article is written after the extraction, compilation and integration of multiple information for exchange and learning purposes. The copyright of the summary information still belongs to the original article and its author. If any infringement is found, please contact us to delete it. 

Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
FDA Proposes Foreign Tobacco Factory Registration Rule to Tighten Import Oversight
FDA Proposes Foreign Tobacco Factory Registration Rule to Tighten Import Oversight
The FDA has proposed a rule requiring foreign tobacco manufacturers to register facilities and list products before exporting to the U.S. If finalized, the rule could affect overseas OEM/ODM factories, contract manufacturers, specification developers, bulk product makers, and repackaging or relabeling firms. FDA says the proposal would help identify unauthorized imported tobacco products, including e-cigarettes.
Special Report
Jun.26
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
Altria’s USSTC to Close Nashville Plant and Shift Operations to Kentucky by 2028
U.S. Smokeless Tobacco Company (USSTC), a subsidiary of Altria Group, announced plans to close its Nashville manufacturing facility by 2028 and consolidate production operations at a new facility in Hopkinsville, Kentucky.
Market
Jun.02
Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices
Maine Approves Vape Stewardship Bill Requiring Producers to Manage End-of-Life Devices
The Maine Legislature has passed LD 1519, a bill that would establish a producer-funded stewardship program for electronic smoking devices, requiring manufacturers and importers to manage the collection, transportation, recycling and disposal of end-of-life products, particularly disposable vapes containing lithium-ion batteries.
Jun.12
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
AHA Journal Study: WS-23 Triples Premature Heartbeats, Raising Concerns Over Vape Cooling Agents
A University of Louisville research team published a study in an American Heart Association journal suggesting that synthetic cooling agents used in e-cigarettes, including WS-3 and WS-23, may disrupt cardiac electrical activity and increase arrhythmia risk. In animal experiments, WS-23 tripled premature heartbeats.
Jun.16
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
Virginia Tightens Vape and Tobacco Retail Enforcement, With Fines Up to $15,000 Per Unlisted Product
A new Virginia law that took effect on July 1, 2026, requires retailers to obtain permits to sell liquid nicotine, vape and tobacco products, while directing Virginia ABC to conduct inspections and verify that stores sell only products listed in the state directory.
Jul.20